Pharmagreen Biotech Inc (PHBI)
0.0006
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Pharmagreen Biotech 1 Year Total Returns (Daily): -83.33% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -83.33% |
May 16, 2024 | -77.78% |
May 15, 2024 | -80.26% |
May 14, 2024 | -80.00% |
May 13, 2024 | -79.00% |
May 10, 2024 | -77.38% |
May 09, 2024 | -74.59% |
May 08, 2024 | -83.33% |
May 07, 2024 | -77.50% |
May 06, 2024 | -81.25% |
May 03, 2024 | -81.25% |
May 02, 2024 | -81.96% |
May 01, 2024 | -82.50% |
April 30, 2024 | -81.25% |
April 29, 2024 | -85.00% |
April 26, 2024 | -85.11% |
April 25, 2024 | -83.33% |
April 24, 2024 | -83.33% |
April 23, 2024 | -83.56% |
April 22, 2024 | -83.56% |
April 19, 2024 | -87.12% |
April 18, 2024 | -81.05% |
April 17, 2024 | -83.75% |
April 16, 2024 | -81.40% |
April 15, 2024 | -79.07% |
Date | Value |
---|---|
April 12, 2024 | -83.17% |
April 11, 2024 | -82.18% |
April 10, 2024 | -80.00% |
April 09, 2024 | -81.82% |
April 08, 2024 | -80.68% |
April 05, 2024 | -86.55% |
April 04, 2024 | -87.20% |
April 03, 2024 | -82.02% |
April 02, 2024 | -87.50% |
April 01, 2024 | -87.50% |
March 28, 2024 | -84.54% |
March 27, 2024 | -87.00% |
March 26, 2024 | -86.00% |
March 25, 2024 | -86.00% |
March 22, 2024 | -86.54% |
March 21, 2024 | -88.46% |
March 20, 2024 | -88.24% |
March 19, 2024 | -87.00% |
March 18, 2024 | -88.00% |
March 15, 2024 | -84.44% |
March 14, 2024 | -83.51% |
March 13, 2024 | -85.26% |
March 12, 2024 | -89.06% |
March 11, 2024 | -89.06% |
March 08, 2024 | -85.42% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.78%
Minimum
May 20 2019
293.8%
Maximum
Nov 08 2021
-65.95%
Average
-75.50%
Median
Jan 22 2020
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -19.40% |
Perspective Therapeutics Inc | 252.7% |
Protalix BioTherapeutics Inc | -51.69% |
Electromed Inc | 32.31% |
Armata Pharmaceuticals Inc | 107.2% |